ME Meningoencephalitis Advantage Test
Comprehensive Central Nervous System Infection Detection
The ME Meningoencephalitis Advantage Test represents a revolutionary advancement in neurological diagnostics, providing healthcare providers with rapid, comprehensive screening for central nervous system infections. This state-of-the-art multiplex PCR panel simultaneously detects multiple pathogens that can cause life-threatening conditions like meningitis and encephalitis, enabling faster diagnosis and more targeted treatment approaches.
What Does This Test Measure?
This advanced diagnostic panel utilizes Film Array Multiplex PCR and LAMP technology to detect a comprehensive range of pathogens in cerebrospinal fluid:
- Bacterial Pathogens: Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae
- Viral Agents: Cytomegalovirus, Enterovirus, Herpes simplex virus 1, Herpes simplex virus 2, Human herpesvirus 6, Human parechovirus, Varicella zoster virus
- Fungal Detection: Cryptococcus neoformans/gattii
- Additional Testing: TB LAMP Qualitative DNA for Mycobacterium tuberculosis complex
Who Should Consider This Test?
This comprehensive CNS infection panel is recommended for individuals experiencing symptoms suggestive of central nervous system infections:
- Patients with severe headaches accompanied by fever and neck stiffness
- Individuals experiencing confusion, altered mental status, or behavioral changes
- Those with photophobia (sensitivity to light) and phonophobia (sensitivity to sound)
- Patients with seizures, especially new-onset seizures
- Individuals with focal neurological deficits or weakness
- Immunocompromised patients with neurological symptoms
- Neonates and infants with fever and irritability
Key Benefits of ME Meningoencephalitis Testing
- Rapid Diagnosis: Same-day results when samples are submitted by 1pm
- Comprehensive Coverage: Detects 14+ pathogens in a single test
- Early Intervention: Enables prompt initiation of appropriate antimicrobial therapy
- Reduced Hospital Stay: Faster diagnosis can lead to shorter hospitalization periods
- Targeted Treatment: Helps avoid unnecessary broad-spectrum antibiotics
- Improved Outcomes: Early detection correlates with better neurological recovery
Understanding Your Test Results
Your ME Meningoencephalitis Advantage Test results will provide clear, actionable information:
- Positive Results: Indicate detection of specific pathogens, guiding targeted antimicrobial therapy
- Negative Results: Help rule out common CNS infections, allowing investigation of alternative diagnoses
- Quantitative Data: Some pathogens may include semi-quantitative information to guide treatment intensity
- Clinical Correlation: Results should always be interpreted in the context of clinical presentation and other laboratory findings
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ME Meningoencephalitis Advantage Test | $608 USD | $676 USD |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Action for Your Neurological Health
Don’t wait when neurological symptoms appear. Early detection of central nervous system infections can significantly impact treatment outcomes and recovery. Our ME Meningoencephalitis Advantage Test provides the comprehensive, rapid diagnostic information needed to guide appropriate medical care.
Call +1(267) 388-9828 today to schedule your ME Meningoencephalitis Advantage Test or to speak with our neurological testing specialists. Same-day testing available at locations nationwide.
